CollabRx Snags ASCO Partnership

Palo Alto, CA-based CollabRx, a developer of web-based applications to help connect cancer patients and researchers, is announcing today it has formed a partnership with the largest association of cancer physicians—the American Society of Clinical Oncology. Under the collaboration, ASCO will provide CollabRx with access to all its published content, and make CollabRx’s Targeted Therapy Finder available online to its 30,000 members. CollabRx’s first app is designed to help personalize treatment options for patients with melanoma, a deadly form of skin cancer. I wrote about CollabRx founder Jay “Marty” Tenenbaum, and his quest to better connect patients and researchers, in a feature about an open source database called Cancer Commons.

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.